LONIGUTAMAB
UNII 56GN9PT35D

Substance Identification & Data

This profile provides standardized clinical and technical data for Lonigutamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 56GN9PT35D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2362015-67-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

56GN9PT35D

CAS Registry Number

2362015-67-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LONIGUTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C184844

National Cancer Institute reference terminology for clinical and research data.

INN ID

11639

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lonigutamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LONIGUTAMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL HZ208F2-4 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HZ208F2-4 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IGF1R (INSULIN LIKE GROWTH FACTOR 1 RECEPTOR, IGF1-R, IGF-1R, CD221)), HUMANIZED MONOCLONAL ANTIBODY

LONIGUTAMAB [INN]